A multicenter, open-label, phase 1a study of HC-5404 in patients with advanced solid tumors.Arkadiusz Z. Dudek, J. L. Mesías Iglesias, Eric S. Lightcap et al.|Journal of Clinical Oncology|2024Cited by 13
Activation of GCN2 By HC-7366 Results in Significant Anti-Tumor Efficacy As Monotherapy and Overcomes Resistance Mechanisms When Combined with Venetoclax in AMLFeven Tameire, Nandita Bose, Michael E. Stokes et al.|Blood|2023Cited by 3